Connect with us

health

Lagos Mandatory Health Insurance Enforcement Begins Early 2026

Published

on

Lagos Mandatory Health Insurance

Lagos Mandatory Health Insurance will begin enforcement in 2026, with LASHMA urging residents to enrol early under Governor Sanwo-Olu’s Executive Order

adron lemon friday

Lagos Mandatory Health Insurance will officially begin enforcement in early 2026, according to the Lagos State Health Management Agency (LASHMA).

Also read: Mental Health Public Policy Gains Emotional Boost at Lagos Assembly Lecture

The announcement came during the 2025 ILERA EKO Annual Provider Forum held in Ikeja on Wednesday.

The Permanent Secretary of LASHMA, Dr Emmanuella Zamba, said the enforcement followed Governor Babajide Sanwo-Olu’s Executive Order issued in July 2024.

She emphasised that the government was committed to full implementation while ensuring residents were adequately informed beforehand.

“We want all residents to be aware and onboard before enforcement begins,” Dr Zamba stated, urging Lagosians to register for the scheme as a financial safeguard against health emergencies.

She noted that LASHMA had empanelled over 865 healthcare providers and transitioned critical operational tasks—such as service authorisations and claims vetting—from third-party administrators to an internal team.

“This has led to faster turnaround times and improved oversight,” she said.

One of the key innovations introduced by the agency is the biometric verification system.

Developed in partnership with the Lagos State Residents Registration Agency, it enables real-time identity confirmation and aims to curb fraud in the health sector.

“This technological innovation helps us ensure that enrollees receive timely, targeted care,” she added.

The event’s theme, “Driving Universal Health Coverage through Strategic Partnerships,” reflected the agency’s goal to use collaboration as a vehicle to scale healthcare access. Dr Zamba encouraged attendees to treat the forum as a platform for co-creation.

“This is your platform to share insights, highlight challenges, and co-develop solutions with us. Together, we can build a more resilient health system,” she said.

We want all residents to be aware and onboard before enforcement begins.

Chairman of the LASHMA Board, Dr Adebayo Adedewe, delivered the keynote address.

He praised healthcare providers for their dedication, calling them the cornerstone of the ILERA EKO scheme.

“Your commitment has propelled our shared journey toward Universal Health Coverage,” Dr Adedewe said.

He stressed that trust and collaboration were essential for scaling the scheme’s impact across the state.

Several provider-focused reforms were also highlighted during the forum.

These included performance-based categorisation, timely supply of essential medicines, and revised tariffs to cushion economic pressures.

“We’ve also expanded access by incorporating community pharmacies into the scheme, ensuring continuity of care and broader reach,” he added.

Dr Adedewe also lauded the political will behind the initiative.

He explained that Lagos remains the first and only state in Nigeria to treat the health equity fund as a first-line charge in the budget.

“From ₦1 billion in 2024, Mr Governor increased it to ₦3 billion this year, demonstrating true leadership and a firm commitment to equity,” he said.

With enforcement of Lagos Mandatory Health Insurance set for 2026, the state government and its partners are racing to get as many residents as possible enrolled.

Officials stressed the importance of early compliance to avoid disruptions when enforcement begins.

Also read: Lagos penalizes 580 restaurants, nightclubs over indoor smoking violations

The forum concluded with a renewed call for strategic partnerships, provider engagement, and public education to meet the state’s Universal Health Coverage goals by the end of the decade.

62 / 100 SEO Score

News

NAFDAC Finds 11,400 Cartons of Banned Chemicals

Published

on

NAFDAC has uncovered nearly 11,400 cartons of banned agrochemicals, including Paraquat products, in Kano warehouses, raising fresh concerns about food safety and regulatory enforcement

(more…)

adron lemon friday

70 / 100 SEO Score
Continue Reading

health

FCCPC Moves Against Producers Over Poorly Fortified Oil, Salt

Published

on

FCCPC orders producers to comply with food fortification standards after a survey found inadequately fortified vegetable oil and salt in Nigerian markets

(more…)

adron lemon friday

68 / 100 SEO Score
Continue Reading

health

UK Tests Five-Day Breast Cancer Radiotherapy in Major Trial

Published

on

The UK is testing five-day breast cancer radiotherapy in a major trial that could reduce hospital visits and treatment costs for patients

The United Kingdom has launched a major clinical trial involving more than 1,000 participants to determine whether breast cancer radiotherapy can be shortened from three weeks to five days without compromising its effectiveness in preventing the disease from returning.

Also read: Grey CEO Urges Africa to Ditch Dollar for Trade

adron lemon friday

The government-funded FAST-Forward Boost trial, being conducted at 39 hospitals across the UK, will investigate whether a shorter course of radiotherapy combined with an additional targeted dose, known as a boost, can provide effective treatment for patients following breast cancer surgery.

The UK Department of Health and Social Care announced the development on Friday, October 30, describing the study as part of efforts to improve cancer treatment and make care more convenient for patients.

Led by the Institute of Cancer Research in London and funded by the National Institute for Health and Care Research, the study aims to recruit 4,830 participants by 2028.

Those enrolled will be followed up for five years, with results expected in 2033.

If the approach proves successful, it could reduce the number of hospital visits required by patients, potentially saving them 10 journeys compared with the existing three-week treatment schedule.

The department said the shorter schedule could also reduce transport expenses and the time patients spend away from work and family.

It could additionally ease pressure on the National Health Service by freeing up radiotherapy capacity for other patients.

Health and Social Care Secretary Yvette Cooper said the trial reflected the country’s efforts to use medical research to improve cancer care.

“This trial shows how the UK is using our world beating research capabilities to pursue huge improvements and transformations in cancer treatment for patients,” she said.

Why the radiotherapy trial matters

Radiotherapy uses carefully targeted radiation to destroy cancer cells or prevent them from growing.

For many people with breast cancer, it is recommended after surgery to reduce the risk of the disease returning in the treated area.

A treatment boost involves delivering an additional dose of radiation to the area considered to have a higher risk of recurrence, usually the site where the tumour was removed.

The FAST-Forward Boost trial is examining how this additional treatment can be incorporated into a shorter schedule.

Reducing treatment from three weeks to five days could make a considerable difference to patients who must travel regularly to hospitals.

The impact may be particularly significant for people living far from specialist cancer centres, those with limited transport options and patients balancing treatment with employment or family responsibilities.

However, the trial is designed to establish whether the shorter approach is effective and safe for the patients being studied. Its results will be important in determining whether the treatment schedule can become a wider option in clinical practice.

UK expands breast cancer screening efforts

The announcement comes as the British government intensifies efforts to improve breast cancer screening, encourage early diagnosis and strengthen support for patients.

The Department of Health and Social Care said screening uptake among women receiving their first invitation had risen to 63.6 per cent, its highest level in a decade.

Despite the improvement, around four in 10 women invited for their first screening appointment still do not attend.

The government is also working with the National Institute for Health and Care Research and NHS England on studies examining how artificial intelligence could support the analysis of mammograms.

The technology is being explored as a way to assist the assessment of breast screening images, although its role and effectiveness must be established through appropriate research and clinical evaluation.

In addition, the government has partnered with breast cancer charity Breast Cancer Now for three years to help women recognise symptoms, find reliable information and access support after treatment.

Together, the initiatives reflect a broader approach to breast cancer care, combining screening, research into treatment improvements and support for people living with the disease.

Also read: Grey CEO Urges Africa to Ditch Dollar for Trade

For now, the five-day radiotherapy approach remains under investigation. With final results not expected until 2033, the FAST-Forward Boost trial will need to establish whether reducing treatment time can deliver comparable cancer control while maintaining patient safety.

65 / 100 SEO Score
Continue Reading

Trending News